Advances in systemic targeted therapy and immunotherapy have dramatically improved outcome at least in some types of solid cancer. However, metastasis to the central nervous system remains a major diagnostic and therapeutic challenge, notably in long-term survivors with cancers.
Universitätsspital Zürich, Rämistrasse 100, 8091 Zürich
Hörsaal NORD
22.01.2025
09:00 - 17:00
tbd
Free of charge
| 9 am | Welcome |
| 9.05 am | Session 1 Andreas Wicki, University Hospital Zurich |
| 9.10 am | CSF analysis in CNS metastases |
| 9.40 am | Pharmacoscopy in brain metastases Berend Snijder, ETH Zurich |
| 10.10 am | Coffee Break |
| 10.30 am | Patients voice for CNS mets Helen Bulbeck , Brainstrust UK |
| 11 am | Medical challenges for CNS metastases Evangelia Razis, Hygeia Hospital, Athen |
| 11.25 am | Session 2 Michael Weller, University Hospital Zurich |
| 11.30 am | RANO RESECT Group Joerg Christian Tonn, Med. University Munich, Germany |
| 12 am | Evidence for gross total resection of Brain Metastases Stefanos Voglis, University Hospital Zurich |
| 12.30 pm | Lunch Break |
| 1.30 pm | SRS for multiple brain metastases and leptomeningeal metastases Luis Schiappacasse, CHUV Lausanne |
| 2 pm | Re-irradiation: how far can we go? Nicolaus Andratschke, University Hospital Zurich |
| 2.25 pm | Session 3 Matthias Guckenberger, University Hospital Zurich |
| 2.30 pm | AIMRIBM: Artificial Intelligence applied to MRI for CNS metastases Florian Putz, UK Erlangen, Germany |
| 3 pm | Theranostics in CNS metastases Martin Hüllner, University Hospital Zurich |
| 3.30 pm | Coffee Break |
| 3.50 pm | European research and challenges in CNS metastases Emilie Le Rhun, University Hospital Zurich |
| 4.15 pm | Keynote Lecture Emilie Le Rhun, University Hospital Zurich |
| 4.20 pm | Keynote Lecture tbd |
| 4.50 pm | Wrap Up Matthias Guckenberger, University Hospital Zurich |
Here we invite you to our 6th Zurich Brain Metastasis Symposium that will provide state-of-the-art presentations on current and future diagnostic and therapeutic approaches for patients with brain and leptomeningeal metastasis.
Please register by 22.01.2025.